Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$6.96 USD
-0.26 (-3.60%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $6.96 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.95 | 1.56 | 9.99 |
Current Quarter Estimate | -1.54 | 0.26 | 63.00 |
Year Ago Quarter Estimate | -2.81 | -0.05 | 52.25 |
Next Quarter Estimate | -1.45 | -1.84 | 66.00 |
Next Year Estimate | -5.11 | 12.89 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 28.51 | 20.10 | 15.67 |
Next Year | 21.02 | 16.80 | 11.34 |
Last 5 Years | -457.20 | 7.80 | 8.10 |
Next 5 Years | 20.70 | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.09 |
Price/Book (MRQ) | 0.68 | 1.51 |
Price/Cash Flow (MRFY) | NA | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -458.30% | -56.43% |
Return on Equity (TTM) | -55.87% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.